Revelation Biosciences Inc (REVB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.43M
Last updated: Nov 17, 2026 at 11:00 AM ET
Revelation Biosciences Inc (REVB) Competitors
The companies most similar to Revelation Biosciences are Purple Biotech (PPBT), BioRestorative Therapies (BRTX) and Ernexa Therapeutics (ERNA). By market cap, Revelation Biosciences ranks 8th of the 13 companies on this page; Reviva Pharmaceuticals Holdings (RVPH) is the largest at $4.63M.
Peer Comparison
REVB's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Revelation Biosciences (REVB) | $2.43M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Purple Biotech (PPBT) | $2.65M | N/A | N/A | 0.0% | -156.2% | 0.0% | 0.00% |
| BioRestorative Therapies Inc (BRTX) | $2.06M | N/A | 70.3x | 0.0% | -289.9% | -7.3% | 0.00% |
| Ernexa Therapeutics Inc. (ERNA) | $2.84M | N/A | N/A | 0.0% | N/A | -94.1% | 0.00% |
| Calidi Biotherapeutics Inc. (CLDI) | $2.29M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Enlivex Therapeutics Ltd (ENLV) | $1.82M | N/A | N/A | 0.0% | -0.3% | 0.0% | 0.00% |
| GRI Bio Inc. (GRI) | $3.72M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Reviva Pharmaceuticals Holdings Inc. (RVPH) | $4.63M | N/A | N/A | 0.0% | -90.2% | 0.0% | 0.00% |
| Jupiter Neurosciences, Inc. Common Stock (JUNS) | $2.32M | N/A | 21.0x | 0.0% | 1154.5% | 0.0% | 0.00% |
| PharmaCyte Biotech Inc (PMCB) | $3.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Curis Inc (CRIS) | $2.97M | N/A | 1.6x | 0.0% | N/A | -66.0% | 0.00% |
| Bioatla Inc (BCAB) | $2.89M | N/A | N/A | 0.0% | N/A | 31.6% | 0.00% |
| HCW Biologics Inc (HCWB) | $1.73M | N/A | 0.2x | -83.1% | -51.6% | 1970.0% | 0.00% |
| Peer median | $2.75M | N/A | 11.3x | 0.0% | -70.9% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Revelation Biosciences, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Purple Biotech (PPBT) | Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United... | PPBT competitors |
| BioRestorative Therapies Inc (BRTX) | BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue... | BRTX competitors |
| Ernexa Therapeutics Inc. (ERNA) | Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients. | ERNA competitors |
| Calidi Biotherapeutics Inc. (CLDI) | Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. | CLDI competitors |
| Enlivex Therapeutics Ltd (ENLV) | Enlivex Therapeutics Ltd. is a clinical stage immunotherapy company. The company is headquartered in Nes Ziona, Israel. | ENLV competitors |
| GRI Bio Inc. (GRI) | GRI Bio Inc. is an innovative biotechnology company focused on leveraging microbiome technology to develop cutting-edge therapeutics in immunology and oncology. | GRI competitors |
| Reviva Pharmaceuticals Holdings Inc. (RVPH) | Reviva Pharmaceuticals Holdings Inc. (RVPH) is a clinical-stage biopharmaceutical company dedicated to developing groundbreaking therapies for central nervous... | RVPH competitors |
| Jupiter Neurosciences, Inc. Common Stock (JUNS) | Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company... | JUNS competitors |
| PharmaCyte Biotech Inc (PMCB) | PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United... | PMCB competitors |
| Curis Inc (CRIS) | Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States. | CRIS competitors |
| Bioatla Inc (BCAB) | BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapies for the treatment of various cancers. | BCAB competitors |
| HCW Biologics Inc (HCWB) | HCW Biologics Inc is a forward-thinking biotechnology company focused on pioneering immunotherapies and vaccine technologies to tackle pressing health issues... | HCWB competitors |
Frequently Asked Questions About REVB
Who are Revelation Biosciences' main competitors?
The companies most similar to Revelation Biosciences include Purple Biotech (PPBT), BioRestorative Therapies (BRTX), Ernexa Therapeutics (ERNA), Calidi Biotherapeutics (CLDI) and Enlivex Therapeutics (ENLV), listed from the closest match.
Who is Revelation Biosciences' biggest competitor?
Reviva Pharmaceuticals Holdings (RVPH) is the largest of the similar companies at $4.63M; Purple Biotech (PPBT) is the closest match by business profile, size, sector and industry.
How does REVB stock compare with its competitors?
REVB's net margin is 0.0% against a peer median of 0.0%.
Which of Revelation Biosciences' competitors pays a higher dividend?
Revelation Biosciences pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Revelation Biosciences bigger than its competitors?
No. Revelation Biosciences is 8th by market cap among the 13 companies on this page; the largest is Reviva Pharmaceuticals Holdings (RVPH) at $4.63M.
REVB pages: Overview, Earnings, Forecast, Financials, Competitors